Standardization and quality control of PCR analyses

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 2, 2000, Pages 87-91

  Burkardt, Hans Joachim ^a,b  

^a Roche Diagnostics   (Switzerland)

^b NONE   (Switzerland)

Author keywords

Diagnostics; False negative; False positive; PCR; Quality control

Indexed keywords

CONFERENCE PAPER; DIAGNOSTIC ERROR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION;

EID: 0034107679     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.014     Document Type: Conference Paper

References (24)

1. Lo Y, Mehal WZ, Fleming K. False positive results and the polymerase chain reaction. Lancet 1990; 1:679.
2. Persing DH. Polymerase chain reaction: trenches to benches. J Clin Microbiol 1990; 29:1281-5.
3. Innis MA, Gelfand DH. Optimization of PCRs. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. PCR protocols. A guide to methods and applications. San Diego: Academic Press, 1990:3-12.
4. White JT. Amplification product detection methods. In: Persing DH, Smith TF, Tenover CF, White JT, eds. Diagnostic molecular microbiology principles and applications. Washington: American Society for Microbiology, 1993:138-48.
5. Finckh U, Lingenfelter PA, Myerson D. Producing single-stranded DNA probes with the Taq DNA polymerase: a high yield protocol. Bio Techniques 1991; 10:35-9.
6. Kwok S. Procedures to minimize PCR-product carry-over. In: Innis AM, Gelfand DH, Sninsky JJ, White TJ, eds. PCR protocols. A guide to methods and applications. San Diego: Academic Press, 1990:142-5.
7. Mc Creedy BJ, Callaway TH. Laboratory design and work flow. In: Persing DH, Smith TF, Tenover CF, White JT, eds. Diagnostic molecular microbiology principles and applications. Washington: American Society for Microbiology, 1993:149-59.
8. Longo MC, Berninger MS, Hartley JL. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 1990; 93:125-8.
9. Morre SA, Sillekens PT, Jacobs MV, de-Blok S, Ossewaarde JM, van Aarle P, et al. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification. Mol Pathol 1998; 51:149-54.
10. Gaydos CA, Crotchfelt KA, Howell MR, Kralian S, Hauptman P, Quinn TC. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infectious Diseases 1998; 117:417-24.
11. Workowski KA, Lampe MF, Wong KG, Watts MB, Stamm WE. Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infection. JAMA 1995; 270:2071-5.
12. Vogels WH, van Voorst-Vader PC, Schroder FP. Chlamydia trachomatis infection in a high-risk population: comparison of polymerase chain reaction and cell culture for diagnosis and follow-up. J Clin Microbiol 1993; 31:1103-7.
13. Ossewaarde JM, Plantema FH, Rieffe M, Nawrocki RP, de Vries A, van Loon AM. Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis. Eur J Clin Microbiol Infectious Diseases 1992; 11:693-7.
14. Rosenstraus M, Wang Z, Chang SY, De Bonville D, Spadoro JP. An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance. J Clin Microbiol 1998; 36:191-7.
15. Rolfs A, Schuller I, Finckh U, Weber-Rolfs I. Substances affecting PCR: inhibition or enhancement. In: Rolfs A, Schuller I, Finckh U, Weber-Rolfs I, eds. PCR: clinical diagnostics and research. Berlin: Springer Verlag, 1992:51-60.
16. Mahony J, Chong S, Jang D, Luinstra K, Faught M, Dalby D, et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplivication: identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 1998; 36:3122-6.
17. Toye B, Woods W, Bobrowska M, Ramotar K. Inhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing. J Clin Microbiol 1998; 36:2356-8.
18. Verkooyen RP, Luijendijk A, Huisam WM, Goessens WH, Kluytmans JA, van Rijsoort Vos JH, et al. Detection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay. J Clin Microbiol 1996; 34:3072-4.
19. Berg ES, Anestad G, Moi H, Storvold G, Skaug K. False-negative results of a ligase chain reaction assay to detect Chlamydia trachomatis due to inhibitors in urine. Eur J Clin Microbiol Infectious Diseases 1997; 16:727-31.
20. Lichtinghagen R, Glaubitz R. A principle of quality assessement using a competitive polymerase chain reaction assay for the detection of Chlamydia trachomatis on cervical specimens. Eur J Clin Chem Clin Biochem 1996; 34:765-70.
21. Goergen B, Jakobs S. Purification of HCV RNA from serum for PCR-A comparison between QIAamp and acid phenol extraction. QIAGEN News 1994:1-11.
22. Noordhoek GT, van Embden JD, Kolk AH. Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J Clin Microbiol 1996; 34:2522-5.
23. Noordhoek GT, Kolk AH, Bjune G, Catty D, Dale JW, Fine PE, et al. Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol 1994; 32:277-84.
24. Lelie PN, Cuypers HTM, Van Drimmelen AAJ, Quint WGV. Quality assessment of hepatitis C virus nucleic acid amplification methods. An international proficiency study. Infusionstherapie und Transfusionsmedizin 1998; 25:102-10.